Aeonmed Medical Treatment is a technology company.
Aeonmed Medical Treatment has raised $4.0M across 1 funding round.
Aeonmed Medical Treatment has raised $4.0M in total across 1 funding round.
Aeonmed, officially Beijing Aeonmed Co., Ltd., is a China-based manufacturer and supplier of medical equipment focused on operating rooms (OR) and intensive care units (ICU).[1][2][4][5][6] Founded in 2001 and headquartered in Beijing, the company develops and produces anesthesia machines, ventilators, operating tables, surgical lights, patient monitors, infusion pumps, ceiling pendants, and digital solutions for OR and ICU environments, addressing two core segments: anesthesia/OR solutions and mechanical ventilation/respiratory management.[2][5][6] It serves hospitals, emergency services, and global healthcare providers by delivering comprehensive system solutions like laminar flow systems, centralized gas supply, and information integration, with a mission to "guard life sincerely" through reliable quality and thoughtful service.[5][6]
Aeonmed has demonstrated growth through expanded product lines, international certifications (e.g., CE for anesthesia machines in 2005), and pivotal roles in disaster response, such as supplying ventilators for earthquakes and the Olympics.[2][5] Its momentum includes rapid domestic distribution expansion since 2006, ERP and call center implementations, and partnerships like joint research centers with military hospitals.[5]
Aeonmed was established in 2001 in Beijing, China, as a domestic leader in R&D and manufacturing for anesthesia and respiratory equipment.[2][3][6] The company's early focus on ventilators and anesthesia machines gained traction during major disasters, including the Wenchuan ("512") earthquake in 2008 and others, where its portable transport ventilators supported emergency medical efforts in hospitals and during patient transport.[2][5] Key milestones include obtaining its first CE certification for the Aeon 7400A anesthesia machine in 2005, reforming into a shareholding company in 2006, and launching new business lines like IV pumps, medical software, hospital purification, and gas installation engineering.[5]
Pivotal moments humanize its rise: donations of ventilators to Sichuan earthquake victims in 2008, establishment of a "Clinical Research Center" with PLA 301 Hospital, and a "Medical Technology Lab" with NUDT in 2005.[5] These steps, alongside ERP implementation and call center operations in 2006, fueled domestic channel expansion and positioned Aeonmed for global reach, including as the official emergency transport ventilator for the Olympics.[2]
Aeonmed stands out in the medical equipment sector through specialized OR/ICU focus and integrated solutions:
Aeonmed rides the global wave of advanced medical device localization and digital healthcare integration, particularly in emerging markets where demand for affordable, reliable OR/ICU tech surges amid aging populations and post-pandemic respiratory needs.[1][2] Timing aligns with China's push for medical self-sufficiency, enabling Aeonmed to scale from domestic R&D leader to exporter, influencing ecosystems through disaster-proven gear that fills gaps in emergency response and hospital infrastructure.[2][5] Market forces like rising ICU utilization, ventilator shortages exposed by COVID-19 (though pre-dating it), and digitization trends favor its end-to-end solutions, reducing reliance on imports and boosting efficiency in resource-limited settings.[6] By partnering with institutions and expanding software/gas systems, it shapes broader adoption of integrated healthcare tech in Asia and beyond.[5]
Aeonmed is poised to deepen its "Operating Expert of OR & ICU" vision through expanded digital integrations and international exports, capitalizing on trends like AI-enhanced monitoring, remote respiratory care, and sustainable medtech manufacturing.[5][6] Regulatory tailwinds in China and global demand for resilient supply chains could accelerate growth, potentially via new homecare and high-flow therapy lines.[2] Its influence may evolve by leading hybrid OR/ICU ecosystems, influencing startups in medtech via proven disaster-response models—echoing its 2001 origins in life-saving innovation amid crises.[2][5]
Aeonmed Medical Treatment has raised $4.0M in total across 1 funding round.
Aeonmed Medical Treatment's investors include Qiming Venture Partners.
Aeonmed Medical Treatment has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Series A in January 2010.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2010 | $4.0M Series A | Qiming Venture Partners |